ICHR (NASDAQ: ICHR) files Form 144 to sell 19,875 restricted shares
Filing Impact
Filing Sentiment
Form Type
144
Rhea-AI Filing Summary
ICHR notice of proposed sale of 19,875 restricted common shares filed on 02/23/2026.
The filing lists an aggregate offering price of $988,029.98 and reports 34,644,332 shares outstanding as of 02/23/2026. The securities listed are restricted stock grants by grant date and award amounts.
Positive
- None.
Negative
- None.
Insights
Form 144 notifies a proposed resale of restricted common shares totaling 19,875.
The filing shows a proposed sale amount of 19,875 shares with an aggregate offering price of $988,029.98 dated 02/23/2026. The securities listed are identified by grant dates and share counts.
Cash-flow treatment is not detailed beyond the aggregate price; timing and method of sale depend on holder actions and regulatory conditions.
FAQ
What does the ICHR Form 144 disclose?
It discloses a proposed resale of 19,875 restricted common shares with an aggregate offering price of $988,029.98. The filing is dated 02/23/2026 and lists multiple grant dates and share counts for the restricted awards.
What aggregate value is listed on the ICHR Form 144?
The Form 144 shows an aggregate offering price of $988,029.98 associated with the proposed resale of the listed shares. That dollar figure appears on the same cover line dated 02/23/2026 in the excerpt provided.